Home › Funds › MCRAE CAPITAL MANAGEMENT INC › LH

MCRAE CAPITAL MANAGEMENT INC position in LH

LABCORP HOLDINGS INC · Health Care

MCRAE CAPITAL MANAGEMENT INC reported holding 77,924 shares of LH (LABCORP HOLDINGS INC) in its Q3 2026 13F filing — a position valued at US$24.0M, representing 4.50% of its reported portfolio and ranking #3 among its reported holdings. MCRAE CAPITAL MANAGEMENT INC has disclosed LH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)77.92K sh
Reported value held$24.01M
Portfolio Weight4.50%
First reportedQ3 2023
Last changeReduce
Updated2026-10-15

Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR

How MCRAE CAPITAL MANAGEMENT INC's LH position evolved

MCRAE CAPITAL MANAGEMENT INC first disclosed a stake in LH in Q3 2023 at 70,581 shares (US$14.2M). The position peaked in Q3 2025 at 84,471 shares, worth US$24.2M. Across 13 filings, MCRAE CAPITAL MANAGEMENT INC increased the stake 6 time(s), trimmed it 5 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 77,924 shares valued at US$24.0M — a reduction of -3,165 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 70.58K $14.19M New
Q4 2023 73.91K $16.80M Add
Q1 2024 79.75K $17.42M Add
Q2 2024 82.39K $16.77M Add
Q3 2024 83.15K $18.58M Add
Q4 2024 84.45K $19.37M Add
Q1 2025 85.90K $19.99M Add
Q2 2025 85.39K $22.42M Reduce
Q3 2025 84.47K $24.25M Reduce
Q4 2025 84.70K $21.25M Hold
Q1 2026 83.47K $22.27M Reduce
Q2 2026 81.09K $22.70M Reduce
Q3 2026 77.92K $24.01M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LH and 13F data

LH (LABCORP HOLDINGS INC) is a Health Care company. 30 other funds we track also report a position in LH — the largest reported positions include VICTORY CAPITAL MANAGEMENT INC (US$1.35B), Boston Partners (US$854.2M), Allspring Global Investments Holdings, LLC (US$635.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LH

All LH fund holders →

FAQ

How long has MCRAE CAPITAL MANAGEMENT INC held LH?

MCRAE CAPITAL MANAGEMENT INC has disclosed LH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is MCRAE CAPITAL MANAGEMENT INC's current position in LH?

As of Q3 2026, MCRAE CAPITAL MANAGEMENT INC holds 77.92K shares of LH (LABCORP HOLDINGS INC), valued at $24.01M, representing 4.50% of its reported portfolio and ranking #3.

Has MCRAE CAPITAL MANAGEMENT INC been buying or selling LH?

In the latest 13F filing (Q3 2026), MCRAE CAPITAL MANAGEMENT INC reduced its position in LH. The position peaked in Q3 2025 at 84.47K shares.

Which other funds hold LH?

Other major institutional holders of LH include VICTORY CAPITAL MANAGEMENT INC, Boston Partners, Allspring Global Investments Holdings, LLC, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.